Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rinaldo Zurbriggen

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Vaccine|January 28, 2003
Immunostimulating reconstituted influenza virosomesRinaldo Zurbriggen
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 2, 2005
Peptides delivered by immunostimulating reconstituted influenza virosomesNicole Westerfeld, Rinaldo Zurbriggen
Expert Review of Vaccines|April 22, 2011
Influenza virosomes as a vaccine adjuvant and carrier systemChristian Moser, Mario Amacker, Rinaldo Zurbriggen
Wiener Klinische Wochenschrift|November 30, 2006
Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomesNicole Westerfeld, Gerd Pluschke, Rinaldo Zurbriggen
Expert Opinion on Drug Discovery|March 16, 2013
Development of influenza virosome-based synthetic malaria vaccinesClaudia A Daubenberger, Gerd Pluschke, Rinaldo Zurbriggen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate Toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T cellsReinhold Schirmbeck, Petra Riedl, Rinaldo Zurbriggen, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2008
Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trialElisabetta Peduzzi, Nicole Westerfeld, Rinaldo Zurbriggen, et al.
Expert Review of Vaccines|August 6, 2003
Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccineRinaldo Zurbriggen, Ian C Metcalfe, Reinhard Glück, et al.
ACS Chemical Biology|December 14, 2006
Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidateXinyu Liu, Sibylle Siegrist, Mario Amacker, et al.
Expert Review of Vaccines|October 13, 2007
Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizationsChristian Moser, Mario Amacker, Andreas R Kammer, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Vaccine|January 28, 2003
Immunostimulating reconstituted influenza virosomesRinaldo Zurbriggen
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 2, 2005
Peptides delivered by immunostimulating reconstituted influenza virosomesNicole Westerfeld, Rinaldo Zurbriggen
Expert Review of Vaccines|April 22, 2011
Influenza virosomes as a vaccine adjuvant and carrier systemChristian Moser, Mario Amacker, Rinaldo Zurbriggen
Wiener Klinische Wochenschrift|November 30, 2006
Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomesNicole Westerfeld, Gerd Pluschke, Rinaldo Zurbriggen
Expert Opinion on Drug Discovery|March 16, 2013
Development of influenza virosome-based synthetic malaria vaccinesClaudia A Daubenberger, Gerd Pluschke, Rinaldo Zurbriggen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate Toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T cellsReinhold Schirmbeck, Petra Riedl, Rinaldo Zurbriggen, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2008
Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trialElisabetta Peduzzi, Nicole Westerfeld, Rinaldo Zurbriggen, et al.
Expert Review of Vaccines|August 6, 2003
Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccineRinaldo Zurbriggen, Ian C Metcalfe, Reinhard Glück, et al.
ACS Chemical Biology|December 14, 2006
Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidateXinyu Liu, Sibylle Siegrist, Mario Amacker, et al.
Expert Review of Vaccines|October 13, 2007
Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizationsChristian Moser, Mario Amacker, Andreas R Kammer, et al.
Pageof 4